CEMQ:XETRA:XETRA-iShares Edge MSCIope Quality Factor UCITS (EUR)

ETF | Others |

Last Closing

USD 10.044

Change

-0.12 (-1.18)%

Market Cap

USD 0.53B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.25 (-0.49%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.09 (-0.56%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.05 (-0.19%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.17 (-0.59%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.32 (-1.29%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.46 (-1.02%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

-2.74 (-1.91%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.33 (-0.64%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-1.35 (-1.31%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-8.90 (-1.49%)

USD 80.38B

ETFs Containing CEMQ:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.05% 30% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.05% 28% F 34% F
Trailing 12 Months  
Capital Gain 8.83% 39% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.83% 37% F 41% F
Trailing 5 Years  
Capital Gain 38.39% 64% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.39% 61% D- 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 10.92% 71% C- 69% C-
Dividend Return 10.92% 71% C- 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.35% 46% F 56% F
Risk Adjusted Return 81.76% 78% C+ 81% B-
Market Capitalization 0.53B 67% D+ 59% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.